Rhodium Nanoparticles as a Novel Photosensitizing Agent in Photodynamic Therapy against Cancer
Loading...
Download
Full text at PDC
Publication date
2020
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley Online Library
Citation
A. Machuca, E. Garcia-Calvo, D. S. Anunciação, J. L. Luque-Garcia, Chem. Eur. J. 2020, 26, 7685.
Abstract
Photodynamic therapy (PDT) is a promising alter-native treatment for different types of cancer due to its highselectivity, which prevents healthy tissues from being dam-aged. The use of nanomaterials in PDT has several advantag-es over classical photosensitizing agents, due to their uniqueproperties and their capacity for functionalization. Especiallyinteresting is the use of metallic nanoparticles, which are ca-pable of absorbing electromagnetic radiation and eithertransferring this energy to oxygen molecules for the genera-tion of reactive oxygen species (ROS) or dissipating it asheat. Although previous reports have demonstrated the ca-pacity of Rh derivatives to serve as anti-tumor drugs, to thebest of our knowledge there have been no studies on thepotential use of small-sized Rh nanoparticles as photosensi-tizers in PDT. In this study, 5 nm Rh nanoparticles have beensynthesized and their potential in PDT has been evaluated.The results show that treatment with Rh nanoparticles fol-lowed by NIR irradiation induces apoptosis in cancer cellsthrough a p53-independent mechanism.